{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T13:08:59Z","timestamp":1740143339565,"version":"3.37.3"},"reference-count":41,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2022,6,22]],"date-time":"2022-06-22T00:00:00Z","timestamp":1655856000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000266","name":"Engineering and Physical Sciences Research Council","doi-asserted-by":"publisher","award":["EP\/L016044\/1"],"award-info":[{"award-number":["EP\/L016044\/1"]}],"id":[{"id":"10.13039\/501100000266","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","award":["HBRYHG00"],"award-info":[{"award-number":["HBRYHG00"]}],"id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100007028","name":"Leona M. and Harry B. Helmsley Charitable Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007028","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.ploscompbiol.org"],"crossmark-restriction":false},"short-container-title":["PLoS Comput Biol"],"abstract":"<jats:p>Cell-cell communication is mediated by many soluble mediators, including over 40 cytokines. Cytokines, e.g. TNF, IL1<jats:italic>\u03b2<\/jats:italic>, IL5, IL6, IL12 and IL23, represent important therapeutic targets in immune-mediated inflammatory diseases (IMIDs), such as inflammatory bowel disease (IBD), psoriasis, asthma, rheumatoid and juvenile arthritis. The identification of cytokines that are causative drivers of, and not just associated with, inflammation is fundamental for selecting therapeutic targets that should be studied in clinical trials. As<jats:italic>in vitro<\/jats:italic>models of cytokine interactions provide a simplified framework to study complex<jats:italic>in vivo<\/jats:italic>interactions, and can easily be perturbed experimentally, they are key for identifying such targets. We present a method to extract a minimal, weighted cytokine interaction network, given<jats:italic>in vitro<\/jats:italic>data on the effects of the blockage of single cytokine receptors on the secretion rate of other cytokines. Existing biological network inference methods typically consider the correlation structure of the underlying dataset, but this can make them poorly suited for highly connected, non-linear cytokine interaction data. Our method uses ordinary differential equation systems to represent cytokine interactions, and efficiently computes the configuration with the lowest Akaike information criterion value for all possible network configurations. It enables us to study indirect cytokine interactions and quantify inhibition effects. The extracted network can also be used to predict the combined effects of inhibiting various cytokines simultaneously. The model equations can easily be adjusted to incorporate more complicated dynamics and accommodate temporal data. We validate our method using synthetic datasets and apply our method to an experimental dataset on the regulation of IL23, a cytokine with therapeutic relevance in psoriasis and IBD. We validate several model predictions against experimental data that were not used for model fitting. In summary, we present a novel method specifically designed to efficiently infer cytokine interaction networks from cytokine perturbation data in the context of IMIDs.<\/jats:p>","DOI":"10.1371\/journal.pcbi.1010112","type":"journal-article","created":{"date-parts":[[2022,6,22]],"date-time":"2022-06-22T17:34:47Z","timestamp":1655919287000},"page":"e1010112","update-policy":"https:\/\/doi.org\/10.1371\/journal.pcbi.corrections_policy","source":"Crossref","is-referenced-by-count":6,"title":["A method for the inference of cytokine interaction networks"],"prefix":"10.1371","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6240-1457","authenticated-orcid":true,"given":"Joanneke E.","family":"Jansen","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7580-2567","authenticated-orcid":true,"given":"Dominik","family":"Aschenbrenner","sequence":"additional","affiliation":[]},{"given":"Holm H.","family":"Uhlig","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8079-9358","authenticated-orcid":true,"given":"Mark C.","family":"Coles","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6888-4362","authenticated-orcid":true,"given":"Eamonn A.","family":"Gaffney","sequence":"additional","affiliation":[]}],"member":"340","published-online":{"date-parts":[[2022,6,22]]},"reference":[{"issue":"6","key":"pcbi.1010112.ref001","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s40259-020-00451-w","article-title":"Clinical Trials of IL-12\/IL-23 Inhibitors in Inflammatory Bowel Disease","volume":"34","author":"A Almradi","year":"2020","journal-title":"BioDrugs"},{"issue":"1","key":"pcbi.1010112.ref002","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1136\/gutjnl-2017-314562","article-title":"Randomised trial and open-label extension study of an anti-interleukin-6 antibody in Crohn\u2019s disease (ANDANTE I and II)","volume":"68","author":"S Danese","year":"2019","journal-title":"Gut"},{"issue":"4","key":"pcbi.1010112.ref003","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.immuni.2019.03.017","article-title":"Cytokine networks in the pathophysiology of inflammatory bowel disease","volume":"50","author":"M Friedrich","year":"2019","journal-title":"Immunity"},{"key":"pcbi.1010112.ref004","article-title":"Effectiveness and Safety of Ustekinumab in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis","author":"S Honap","year":"2021","journal-title":"Digestive Diseases and Sciences"},{"issue":"9906","key":"pcbi.1010112.ref005","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/S0140-6736(13)61134-4","article-title":"Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: A randomised, double-blind, placebo-controlled trial","volume":"382","author":"D Baeten","year":"2013","journal-title":"The Lancet"},{"issue":"3","key":"pcbi.1010112.ref006","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/ajgsup.2016.18","article-title":"Therapeutic targets in inflammatory bowel disease: current and future","volume":"3","author":"J Bilsborough","year":"2016","journal-title":"The American Journal of Gastroenterology Supplements"},{"issue":"12","key":"pcbi.1010112.ref007","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1136\/gutjnl-2011-301668","article-title":"Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn\u2019s disease: Unexpected results of a randomised, double-blindplacebo- controlled trial","volume":"61","author":"W Hueber","year":"2012","journal-title":"Gut"},{"issue":"2","key":"pcbi.1010112.ref008","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1136\/annrheumdis-2012-202646","article-title":"Efficacy and safety of secukinumab, a fully human anti-interleukin-17A monoclonal antibody, in patients with moderate-to-severe psoriatic arthritis: A 24-week, randomised, double-blind, placebo-controlled, phase II proof-of-concept trial","volume":"73","author":"IB McInnes","year":"2014","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"1","key":"pcbi.1010112.ref009","doi-asserted-by":"crossref","first-page":"e135","DOI":"10.1038\/ctg.2015.63","article-title":"Loss of Response to Anti-TNFs: Definition, Epidemiology, and Management","volume":"7","author":"G Roda","year":"2016","journal-title":"Clinical and Translational Gastroenterology"},{"issue":"4","key":"pcbi.1010112.ref010","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.jtbi.2010.05.012","article-title":"TNF and IL-10 are major factors in modulation of the phagocytic cell environment in lung and lymph node in tuberculosis: A next-generation two-compartmental model","volume":"265","author":"S Marino","year":"2010","journal-title":"Journal of Theoretical Biology"},{"issue":"4","key":"pcbi.1010112.ref011","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.4049\/jimmunol.1302481","article-title":"Computational Approach To Characterize Causative Factors and Molecular Indicators of Chronic Wound Inflammation","volume":"192","author":"S Nagaraja","year":"2014","journal-title":"Journal of Immunology"},{"issue":"12","key":"pcbi.1010112.ref012","doi-asserted-by":"crossref","first-page":"3332","DOI":"10.1039\/C5MB00488H","article-title":"Computational modeling of cytokine signaling in microglia","volume":"11","author":"WD Anderson","year":"2015","journal-title":"Molecular BioSystems"},{"issue":"Suppl 6","key":"pcbi.1010112.ref013","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1186\/1471-2164-13-S6-S21","article-title":"Mathematical modeling and stability analysis of macrophage activation in left ventricular remodeling post-myocardial infarction","volume":"13","author":"Y Wang","year":"2012","journal-title":"BMC Genomics"},{"key":"pcbi.1010112.ref014","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.cyto.2016.11.013","article-title":"Demystifying the cytokine network: Mathematical models point the way","volume":"98","author":"PA Morel","year":"2017","journal-title":"Cytokine"},{"key":"pcbi.1010112.ref015","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1109\/TAC.1974.1100705","article-title":"A new look at the statistical model identification","volume":"AC-19","author":"H Aikake","year":"1974","journal-title":"IEEE Transactions on Automatic Control"},{"key":"pcbi.1010112.ref016","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/BF02294361","article-title":"Model selection and Akaike\u2019s Information Criterion (AIC): The general theory and its analytical extensions","volume":"52","author":"H Bozdogan","year":"1987","journal-title":"Psychometrika"},{"key":"pcbi.1010112.ref017","doi-asserted-by":"crossref","first-page":"877","DOI":"10.3389\/fphys.2018.00877","article-title":"Role of cytokine combinations on CD4+ T cell differentiation, partial polarization, and plasticity: Continuous network modeling approach","volume":"9","author":"ME Martinez-Sanchez","year":"2018","journal-title":"Frontiers in Physiology"},{"issue":"6","key":"pcbi.1010112.ref018","doi-asserted-by":"crossref","first-page":"e1004324","DOI":"10.1371\/journal.pcbi.1004324","article-title":"A minimal regulatory network of extrinsic and intrinsic factors recovers observed patterns of CD4+ T cell differentiation and plasticity","volume":"11","author":"ME Martinez-Sanchez","year":"2015","journal-title":"PLoS Computational Biology"},{"issue":"1","key":"pcbi.1010112.ref019","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/1752-0509-8-77","article-title":"Information theoretic approach to complex biological network reconstruction: Application to cytokine release in RAW 264.7 macrophages","volume":"8","author":"F Farhangmehr","year":"2014","journal-title":"BMC Systems Biology"},{"issue":"1","key":"pcbi.1010112.ref020","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s12918-015-0226-3","article-title":"Bayesian modeling suggests that IL-12 (p40), IL-13 and MCP-1 drive murine cytokine networks in vivo","volume":"9","author":"SL Field","year":"2015","journal-title":"BMC Systems Biology"},{"issue":"S.1","key":"pcbi.1010112.ref021","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1186\/1471-2105-7-S1-S7","article-title":"ARACNE: An algorithm for the reconstruction of gene regulatory networks in a mammalian cellular context","volume":"7","author":"AA Margolin","year":"2006","journal-title":"BMC Bioinformatics"},{"issue":"Suppl. 6","key":"pcbi.1010112.ref022","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1186\/1471-2105-8-S6-S5","article-title":"Inferring cellular networks\u2014A review","volume":"8","author":"F Markowetz","year":"2007","journal-title":"BMC Bioinformatics"},{"issue":"2","key":"pcbi.1010112.ref023","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.immuni.2014.01.006","article-title":"Transcriptome-based network analysis reveals a spectrum model of human macrophage activation","volume":"40","author":"J Xue","year":"2014","journal-title":"Immunity"},{"issue":"6","key":"pcbi.1010112.ref024","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/bioinformatics\/bti064","article-title":"Reconstructing biological networks using conditional correlation analysis","volume":"21","author":"JJ Rice","year":"2005","journal-title":"Bioinformatics"},{"key":"pcbi.1010112.ref025","article-title":"LASSIM\u2014A network inference toolbox for genome-wide mechanistic modeling","author":"R Magnusson","year":"2017","journal-title":"PLOS Computational Biology"},{"issue":"5, R36","key":"pcbi.1010112.ref026","doi-asserted-by":"crossref","DOI":"10.1186\/gb-2006-7-5-r36","article-title":"The Inferelator: an algorithm for learning parsimonious regulatory networks from systems-biology data sets de novo","volume":"7","author":"R Bonneau","year":"2006","journal-title":"Genome Biology"},{"key":"pcbi.1010112.ref027","article-title":"Perturbation biology links temporal protein changes to drug responses in a melanoma cell line","author":"E Nyman","year":"2020","journal-title":"PLOS Computational Biology"},{"issue":"3","key":"pcbi.1010112.ref028","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/1043-4666(92)90062-V","article-title":"Direct stimulation of cytokines (IL-1\u03b2, TNF-\u03b1, IL-6, IL-2, IFN-\u03b3 and GM-CSF) in whole blood. I. Comparison with isolated PBMC stimulation","volume":"4","author":"D De Groote","year":"1992","journal-title":"Cytokine"},{"issue":"9","key":"pcbi.1010112.ref029","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/sj.gt.3301691","article-title":"Gene tranfer of Fc-fusion cytokine by in vivo electroporation: Application to gene therapy for viral myocarditis","volume":"9","author":"O Adachi","year":"2002","journal-title":"Gene Therapy"},{"issue":"9","key":"pcbi.1010112.ref030","doi-asserted-by":"crossref","first-page":"e74335","DOI":"10.1371\/journal.pone.0074335","article-title":"Lessons learned from quantitative dynamical modeling in systems biology","volume":"8","author":"A Raue","year":"2013","journal-title":"PLoS ONE"},{"issue":"1","key":"pcbi.1010112.ref031","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Y Benjamini","year":"1995","journal-title":"Journal of the Royal Statistical Society: Series B (Methodological)"},{"issue":"15","key":"pcbi.1010112.ref032","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1093\/bioinformatics\/btp358","article-title":"Structural and practical identifiability analysis of partially observed dynamical models by exploiting the profile likelihood","volume":"25","author":"A Raue","year":"2009","journal-title":"Bioinformatics"},{"issue":"21","key":"pcbi.1010112.ref033","doi-asserted-by":"crossref","first-page":"3558","DOI":"10.1093\/bioinformatics\/btv405","article-title":"Data2Dynamics: a modeling environment tailored to parameter estimation in dynamical systems","volume":"31","author":"A Raue","year":"2015","journal-title":"Bioinformatics"},{"key":"pcbi.1010112.ref034","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/1752-0509-6-120","article-title":"Likelihood based observability analysis and confidence intervals for predictions of dynamic models","volume":"6","author":"C Kreutz","year":"2012","journal-title":"BMC Systems Biology"},{"key":"pcbi.1010112.ref035","doi-asserted-by":"crossref","unstructured":"Aschenbrenner D, Quaranta M, Banerjee S, Ilott N, Jansen J, Steere B, et al. Deconvolution of monocyte responses in inflammatory bowel disease reveals an IL-1 cytokine network that regulates IL-23 in genetic and acquired IL-10 resistance. Gut. 2020;(Web).","DOI":"10.1136\/gutjnl-2020-321731"},{"issue":"10","key":"pcbi.1010112.ref036","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S1471-4906(01)02005-1","article-title":"IFN-\u03b3 production by antigen-presenting cells: Mechanisms emerge","volume":"22","author":"DM Frucht","year":"2001","journal-title":"Trends in Immunology"},{"key":"pcbi.1010112.ref037","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1146\/annurev.immunol.15.1.749","article-title":"Cellular responses to interferon-gamma","volume":"15","author":"U Boehm","year":"1997","journal-title":"Annu Rev Immunol"},{"key":"pcbi.1010112.ref038","doi-asserted-by":"crossref","first-page":"847","DOI":"10.3389\/fimmu.2018.00847","article-title":"Crossroads of Tumor Immune Surveillance or Evasion","volume":"9","author":"F Castro","year":"2018","journal-title":"Front Immunol"},{"issue":"6","key":"pcbi.1010112.ref039","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/j.celrep.2019.01.041","article-title":"RNA-Seq Signatures Normalized by mRNA Abundance Allow Absolute Deconvolution of Human Immune Cell Types","volume":"26","author":"G Monaco","year":"2019","journal-title":"Cell Rep"},{"issue":"9","key":"pcbi.1010112.ref040","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1146\/annurev-immunol-042617-053055","article-title":"Translating immunology into therapeutic concepts for inflammatory bowel disease","volume":"36","author":"HH Uhlig","year":"2018","journal-title":"Annual Review of Immunology"},{"issue":"3","key":"pcbi.1010112.ref041","doi-asserted-by":"crossref","first-page":"e779","DOI":"10.1542\/peds.2012-3344","article-title":"Severe early-onset colitis revealing mevalonate kinase deficiency","volume":"132","author":"M Levy","year":"2013","journal-title":"Pediatrics"}],"container-title":["PLOS Computational Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1010112","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T14:42:46Z","timestamp":1727448166000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1010112"}},"subtitle":[],"editor":[{"given":"James R.","family":"Faeder","sequence":"first","affiliation":[]}],"short-title":[],"issued":{"date-parts":[[2022,6,22]]},"references-count":41,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2022,6,22]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pcbi.1010112","relation":{},"ISSN":["1553-7358"],"issn-type":[{"type":"electronic","value":"1553-7358"}],"subject":[],"published":{"date-parts":[[2022,6,22]]}}}